SULT2B1
protein-codingsulfotransferase family 2B member 1, the group of Sulfotransferases, cytosolic
Gene summary
Sulfotransferase enzymes catalyze the sulfate conjugation of many hormones, neurotransmitters, drugs, and xenobiotic compounds. These cytosolic enzymes are different in their tissue distributions and substrate specificities. The gene structure (number and length of exons) is similar among family members. This gene sulfates dehydroepiandrosterone but not 4-nitrophenol, a typical substrate for the phenol and estrogen sulfotransferase subfamilies. Two alternatively spliced variants that encode different isoforms have been described. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~47.3 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0033091
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0033091
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0033091
Submitter: Genomics England PanelApp
Inheritance Pattern: AR
Disease ID:MONDO:0033091
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0017778
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0033091
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Dermatologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to SULT2B1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_177973.2. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 17 | 17 | ||||
| missense | 2 | 2 | 58 | 7 | 4 | 73 |
| nonsense | 1 | 1 | ||||
| start loss | 0 | |||||
| frameshift | 1 | 1 | ||||
| splice donor/acceptor (+/-2bp) | 1 | 1 | 2 | |||
| Total | 5 | 2 | 59 | 24 | 4 | 94 |
Highest pathogenic variant AF is 0.000023569839
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_814444.1 | 7 | MANE Select | |
| Ensembl | ENSP00000201586.2 | 7 | MANE Select | |
| RefSeq | NP_004596.2 | 6 | Standard | |
| Ensembl | ENSP00000312880.3 | 6 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Steroid hormone biosynthesis - Homo sapiens (human)
- 17-Beta Hydroxysteroid Dehydrogenase III Deficiency
- Sulfate/Sulfite Metabolism
- Sulfite oxidase deficiency
- Androgen and Estrogen Metabolism
Biological Process
- sulfate assimilation
- steroid metabolic process
- cholesterol metabolic process
- negative regulation of cell population proliferation
- positive regulation of epidermal cell differentiation
Molecular Function
- nucleic acid binding
- alcohol sulfotransferase activity
- protein binding
- cholesterol binding
- steroid sulfotransferase activity
Cellular Component
- nucleus
- cytoplasm
- endoplasmic reticulum
- cytosol
- intracellular membrane-bounded organelle
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000201586
- Coding exons
- 7
- Length
- 47351
- Individuals with no LoFs
- 125738
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 7
- Defined
- 125745
- p
- 0.0000278
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.11 | 187 | 235 | 0.796 | 0.0000153 | 2367 |
| Missense (PolyPhen) | 49 | 74.923 | 0.654 | 800 | ||
| Synonymous | 0.132 | 99 | 101 | 0.983 | 0.00000741 | 685 |
| Loss of Function | 2.74 | 3 | 14.1 | 0.213 | 5.99e-7 | 164 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000038 | 0.000035 | rare |
| South Asian | 0.000034 | 0.000033 | rare |
| Other | 0.00033 | 0.00033 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate (PAPS) as sulfonate donor to catalyze the sulfate conjugation of many hormones, neurotransmitters, drugs and xenobiotic compounds. Sulfonation increases the water solubility of most compounds, and therefore their renal excretion, but it can also result in bioactivation to form active metabolites. Sulfates hydroxysteroids like DHEA. Isoform 1 preferentially sulfonates cholesterol, and isoform 2 avidly sulfonates pregnenolone but not cholesterol. Plays a role in epidermal cholesterol metabolism and in the regulation of epidermal proliferation and differentiation (PubMed:28575648). {ECO:0000269|PubMed:12145317, ECO:0000269|PubMed:28575648, ECO:0000269|PubMed:9799594}.;
Recessive Scores
- pRec
- 0.576
Intolerance Scores
- LoFtool
- 0.0652
- RVIS EVS
- 0.62
- RVIS percentile EVS
- 83.36
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.998
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |